Crossmark

LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer

Published Online: 2022-10-04

Published Print: 2023-01

Authors

Zheng, Yuxiao

Qi, Feng

Li, Lu https://orcid.org/0000-0002-3211-9212
Yu, Bin

Cheng, Yifei

Ge, Minghui

Qin, Chao https://orcid.org/0000-0003-1915-4272
Li, Xiao https://orcid.org/0000-0002-9358-1136
License Information

Text and Data Mining valid from 2022-10-04

Version of Record valid from 2022-10-04
More Information

Article History

Received: 5 May 2022

Revised: 25 August 2022

Accepted: 12 September 2022

First Online: 4 October 2022

Competing interests

: The authors declare no competing interests.

Document is current